Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Assessing balance and vestibular function after Gammaknife treatment for vestibular schwannoma

Official title: Prospective Study : Long-term Evolution of Balance and Vestibular Function in Patients Treated With Gammaknife Radiosurgery for Vestibular Schwannoma EQUI-GAMMA

Run by University Hospital, Toulouse · NCT04859335 · Data updated 2026-11-12

This study tests how Gammaknife treatment for vestibular schwannomas affects balance and inner ear function in patients who haven't had other treatments.

More Vestibular Schwannoma trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment50 (estimated)
SponsorUniversity Hospital, Toulouse
Academic / other
Locations1 site (Toulouse)
StatusRecruiting
StartedMay 21, 2021
Main results expectedDecember 1, 2028
Study endsDecember 1, 2028
Registry record updatedAugust 11, 2026
Trial IDNCT04859335 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients diagnosed with vestibular schwannomas who are eligible for Gammaknife radiosurgery and have not undergone previous treatments.

Probably not a fit

Patients with a history of prior treatment for vestibular schwannomas or those with associated otological conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effects of Gammaknife radiosurgery on balance and vestibular function in patients with vestibular schwannomas. It aims to comprehensively assess changes in vestibular function and balance using both subjective quality of life questionnaires and objective vestibular assessments. The study focuses on patients with schwannomas smaller than 2.5-3 cm who have not received prior treatment. The results will help clarify the impact of this treatment on patients' balance and overall quality of life.

Why it matters

Potential benefit: If successful, this study could provide valuable insights into the preservation of balance and vestibular function after Gammaknife treatment, improving patient management and outcomes.

How similar studies have gone: While there have been studies on Gammaknife radiosurgery for vestibular schwannomas, comprehensive assessments of vestibular function and balance post-treatment are limited, making this approach relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Vestibular schwannoma's Patients for whom an indication of gammaknife radiosurgery was determined in a dedicated multidisciplinary consultation meeting, having not received previous treatment for this schwannoma.
* Patient affiliated to Social Security
* No opposition to participation

Exclusion Criteria:

* History of prior treatment for the presented vestibular schwannoma (surgery, fractional radiotherapy)
* History of otological or otoneurological pathology associated with schwannoma
* Patient with type 2 neurofibromatosis
* Patient under legal protection
* Pregnant or breastfeeding women

Where it's running

  • CHU Toulouse
    Toulouse, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.